Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

By Zent O.   Banzhoff A.   Hilbert A.K.   Meriste S.   Sluzewski W.   Wittermann C.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3584-3592

Elsevier

Access to resources Recommend Favorite

Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children

By Eder G.   Kollaritsch H.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3575-3583

Elsevier

Access to resources Recommend Favorite

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

By Ehrlich H.J.   Pavlova B.G.   Fritsch S.   Poellabauer E.-M.   Loew-Baselli A.   Obermann-Slupetzky O.   Maritsch F.   Cil I.   Dorner F.   Barrett P.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

By Zent O.   Beran J.   Jilg W.   Mach T.   Banzhoff A.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 738-741

Elsevier

Access to resources Recommend Favorite

Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance

By Clemens R.   Sanger R.   Kruppenbacher J.   Hobel W.   Stanbury W.   Bock H.L.   Jilg W.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 349-352

Elsevier

Access to resources Recommend Favorite